PP_1170x120_10-25-21

taysofy

Amneal launches generic Taytulla

Amneal launches generic Taytulla

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules 1 mg/20 mcg following the July 20th approval of its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration. The Amneal product, marketed under the proprietary of taysofy, is an AB-rated generic equivalent for the

Adheris Health